Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenxie Zhitong
- Development stage
- Phase 1
- Lead developer
- Shuguang Hospital
- Administration
- Oral
01
Overview
Shenxie Zhitong is a Traditional Chinese Medicine (TCM) herbal formula developed by Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. It is primarily indicated for the treatment of sciatica and radiculopathy resulting from lumbar disc herniation. The formula is designed to tonify Qi, activate blood circulation, and alleviate pain, often used in conjunction with acupuncture. It is currently being evaluated in randomized controlled trials to compare its efficacy against standardized non-operative treatments for patients with L5 or S1 radiculopathy.
- Other names
- Shenxie Zhitong decoctionShenxie Zhitong formulaShenxie Zhitong Fang
Beyond the preview
Go deeper on Shenxie Zhitong.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenxie Zhitong.